Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
Jan‐Niklas Eckardt(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Jan Moritz Middeke(Fresenius (Germany)), Michael Krämer(University Hospital Carl Gustav Carus), Tim Schmittmann, Karsten Wendt, Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Anas Shekh Sulaiman(University Hospital Carl Gustav Carus), Sebastian Riechert, Friedrich Stölzel(German Cancer Research Center), Ulrich S. Schuler(University Hospital Carl Gustav Carus), Lisa Wagenführ(University Hospital Carl Gustav Carus), Frank Kroschinsky(University Hospital Carl Gustav Carus), Katja Sockel(Innsbruck Medical University), Johannes Schetelig(University Hospital Carl Gustav Carus), Uwe Platzbecker(National Center for Tumor Diseases), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 75
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
The future landscape of large language models in medicine
|Communications Medicine|2023|937